Next Article in Journal
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors
Next Article in Special Issue
EGCG Prevents the Transcriptional Reprogramming of an Inflammatory and Immune-Suppressive Molecular Signature in Macrophage-like Differentiated Human HL60 Promyelocytic Leukemia Cells
Previous Article in Journal
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells
Previous Article in Special Issue
Updates on the Management of Acute Myeloid Leukemia
 
 
Review

Article Versions Notes

Cancers 2022, 14(20), 4995; https://doi.org/10.3390/cancers14204995
Action Date Notes Link
article xml file uploaded 12 October 2022 11:39 CEST Original file -
article xml uploaded. 12 October 2022 11:39 CEST Update -
article pdf uploaded. 12 October 2022 11:39 CEST Version of Record -
article xml file uploaded 12 October 2022 11:39 CEST Update -
article xml uploaded. 12 October 2022 11:40 CEST Update -
article pdf uploaded. 12 October 2022 11:40 CEST Updated version of record -
article xml file uploaded 12 October 2022 11:40 CEST Update -
article html file updated 12 October 2022 11:40 CEST Original file -
article xml uploaded. 12 October 2022 11:40 CEST Update https://www.mdpi.com/2072-6694/14/20/4995/xml
article pdf uploaded. 12 October 2022 11:40 CEST Updated version of record https://www.mdpi.com/2072-6694/14/20/4995/pdf
article html file updated 12 October 2022 11:41 CEST Update -
article html file updated 12 October 2022 11:41 CEST Update -
article html file updated 28 February 2023 17:41 CET Update -
article html file updated 1 March 2023 21:03 CET Update https://www.mdpi.com/2072-6694/14/20/4995/html
Back to TopTop